share_log

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

AccuStem Science,Inc.宣布董事长购买股份
GlobeNewswire ·  2022/06/09 13:40

LONDON and PHOENIX, Ariz., June 09, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased 20,000 ACUT shares in the open market. This brings his total holdings to 3,821,226 shares.

亚洲网亚利桑那州伦敦和凤凰城6月9日电致力于改善癌症患者预后的生命科学公司AccuStem Sciences,Inc.(场外交易市场代码:ACUT)宣布,董事会主席加布里埃尔·切龙先生已通知公司,他最近在公开市场购买了2万股ACUT股票。至此,他的总持有量达到3821,226股。

About AccuStem

关于AccuStem

AccuStem is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology - to empower patients and their care team with critical answers and tools and drive innovation in healthcare.

AccuStem是一家生命科学公司,致力于优化全球所有癌症患者的预后。该公司从整体上看待其在肿瘤学中的角色-为患者及其护理团队提供关键答案和工具,并推动医疗保健领域的创新。

Media Contact:
Jeff Fensterer
Phone: 415-640-6010
Email: jeff@accustem.com

媒体联系人:
杰夫·芬斯特勒
电话:415-640-6010
电子邮件:Jeff@accustem.com

Investor Contact:
Wendy Blosser
Email: investors@accustem.com

投资者联系方式:
温迪·布洛瑟
电子邮件:Investors@accustem.com


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发